Skip to content
Screener

Roivant Sciences ROIV Price / earnings

Price / earnings at other companies

Amgen logo
AmgenAMGN
22.4×-0.2×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
12.7×-6.6×
AbbVie logo
AbbVieABBV
70.5×-16.6×
Revvity logo
RevvityRVTY
40.9×-3.5×
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
6.2×—

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25B+214%
Enterprise value$25.03B+215%
P/S3,318.5×+2,976×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0×0.0×
Current ratio16.7×-23.8×

Where this comes from

Calculated from Roivant Sciences’s reported figures.

market cap/net income=249.7×

Based on the most recent quarter.

The source filing: Roivant Sciences’s 10-Q, filed February 10, 2025. Open the filing →

Filed
Feb 10, 2025
Fiscal quarter
Q3 FY2024
Calendar quarter
Q4 2024
Accession
0001140361-25-003661

FAQ

What is Roivant Sciences's price / earnings?
Roivant Sciences (ROIV) reported price / earnings of 249.7× in Q4 2024.
How has Roivant Sciences's price / earnings changed year-over-year?
Roivant Sciences's price / earnings increased by 12302.8% year-over-year, from 2× to 249.7×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about Roivant Sciences's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude